These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2908594)

  • 21. Cerebrospinal fluid cytology in patients with leukemias and lymphomas.
    Shankar SK; Verma K
    Indian J Med Res; 1980 Jan; 71():90-5. PubMed ID: 7380515
    [No Abstract]   [Full Text] [Related]  

  • 22. Cytogenetic studies of blast cells in the cerebrospinal fluid in meningeal leukemia.
    Dosik H; Rodriguez J; Verma RS
    Cancer Genet Cytogenet; 1984 May; 12(1):89-91. PubMed ID: 6713363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double marker analysis for terminal deoxynucleotidyl transferase and myeloid antigens in acute nonlymphocytic leukemia patients and healthy subjects.
    Adriaansen HJ; Hooijkaas H; Kappers-Klunne MC; Hählen K; van't Veer MB; van Dongen JJ
    Haematol Blood Transfus; 1990; 33():41-9. PubMed ID: 2323649
    [No Abstract]   [Full Text] [Related]  

  • 24. [Ki-1 non-Hodgkin's lymphoma. A multihospital study of 21 cases].
    Rivas C; Obeso G; Piris M; Castrillo JM; Bellas C; Acevedo A; Martín C; Campo E; Gamallo C; Font M
    Rev Clin Esp; 1989 Mar; 184(5):238-44. PubMed ID: 2549584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morphological and immunohistochemical investigation of non-Hodgkin's lymphoma combined with Hodgkin's disease.
    Hansmann ML; Fellbaum C; Hui PK; Lennert K
    Histopathology; 1989 Jul; 15(1):35-48. PubMed ID: 2548946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central nervous system involvement in non-Hodgkin's lymphoma (excluding Burkitt's lymphoma) in Ugandan Africans.
    Katongole-Mbidde E; Olweny CL; Mugerwa J; Owor R
    East Afr Med J; 1988 Dec; 65(12):838-46. PubMed ID: 3234275
    [No Abstract]   [Full Text] [Related]  

  • 27. CNS involvement in the non-Hodgkin's lymphomas.
    Levitt LJ; Dawson DM; Rosenthal DS; Moloney WC
    Cancer; 1980 Feb; 45(3):545-52. PubMed ID: 6986199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of the nervous system in non-Hodgkin's lymphomas.
    Longpre B; Lamarche J; Rochon M; Lepine M
    Recent Results Cancer Res; 1978; 65():81-7. PubMed ID: 370944
    [No Abstract]   [Full Text] [Related]  

  • 29. Proteomic Biomarker Identification in Cerebrospinal Fluid for Leptomeningeal Metastases with Neurological Complications.
    Galicia N; Díez P; Dégano RM; Guest PC; Ibarrola N; Fuentes M
    Adv Exp Med Biol; 2017; 974():85-96. PubMed ID: 28353226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue polypeptide antigen activity in cerebrospinal fluid: a marker of central nervous system metastases of breast cancer.
    Bach F; Soletormos G; Dombernowsky P
    J Natl Cancer Inst; 1991 Jun; 83(11):779-84. PubMed ID: 2041052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cytologic findings in the cerebrospinal fluid in malignant lymphomas of the central nervous system].
    Jellinger K; Wrchovszky A
    Wien Klin Wochenschr; 1973 Jul; 85(29):522-5. PubMed ID: 4579372
    [No Abstract]   [Full Text] [Related]  

  • 32. Leptomeningeal lymphoma in a child with acquired immune deficiency syndrome.
    Scrigni A; Nastri M; Rodríguez de Schiavi S; Czornyj L; Felice M; Mantese B
    Neuropediatrics; 2006 Jun; 37(3):121-5. PubMed ID: 16967361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis of lymphomatous leptomeningitis by cerebrospinal fluid lymphocyte cell surface markers.
    Goodson JD; Strauss GM
    Am J Med; 1979 Jun; 66(6):1057-9. PubMed ID: 110146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted multiplex validation of CSF proteomic biomarkers: implications for differentiation of PCNSL from tumor-free controls and other brain tumors.
    Ma J; Lin Z; Zhang Y; Ding Y; Tang Q; Qian Y; Jin B; Luo RY; Liao WL; Thyparambil S; Han Z; Chou CJ; Schilling J; Li Q; Zhang M; Lin Y; Ma Y; Sylvester KG; Nagpal S; McElhinney DB; Ling XB; Chen B
    Front Immunol; 2024; 15():1343109. PubMed ID: 39144147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cytomorphological study of the cerebrospinal fluid. II. Leukemias and lymphomas (author's transl)].
    Castro A; Castillo J; Lema M; Dapena MD; Migallón ML; Cebrián E; Noya M
    Med Clin (Barc); 1980 Dec; 75(10):421-4. PubMed ID: 6936571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue polypeptide-specific antigen (TPS) concentrations in cerebrospinal fluid in patients with breast cancer metastases in the central nervous system.
    Sölétormos G; Bach F
    Clin Chem Lab Med; 2001 Feb; 39(2):170-2. PubMed ID: 11341753
    [No Abstract]   [Full Text] [Related]  

  • 37. Secondary central nervous system involvement by non-Hodgkin's lymphoma: the risk factors.
    Liang R; Chiu E; Loke SL
    Hematol Oncol; 1990; 8(3):141-5. PubMed ID: 2373491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of multiparameter flow cytometry of cerebrospinal fluid involved by leukemia/lymphoma cells.
    Babusíková O; Zelezníková T
    Neoplasma; 2004; 51(5):345-51. PubMed ID: 15640938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive factors for central nervous system involvement in non-Hodgkin's lymphoma: significance of very high serum LDH concentrations.
    Tomita N; Kodama F; Sakai R; Koharasawa H; Hattori M; Taguchi J; Fujita H; Tanabe J; Fujisawa S; Fukawa H; Harano H; Kanamori H; Miyashita H; Matsuzaki M; Ogawa K; Motomura S; Maruta A; Ishigatsubo Y
    Leuk Lymphoma; 2000 Jul; 38(3-4):335-43. PubMed ID: 10830740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ferritin in the cerebrospinal fluid as an early indicator of neuromeningeal involvement in patients with malignant lymphoma].
    Aviles A; Gómez R; Salas J
    Gac Med Mex; 1991; 127(3):249-52. PubMed ID: 1800218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.